Sanofi and Regeneron Pharmaceuticals, Inc. announced that the ODYSSEY OUTCOMES trial met its primary endpoint, showing Praluent® (alirocumab) significantly reduced the...
Read more
Forendo Pharma, a drug development company developing novel oral treatments for endometriosis patients, announces that it has been granted a...
Read more
Fidia Farmaceutici announced the positive results of a Phase II study evaluating the efficacy and tolerability of Oncofid®PB, an innovative...
Read more
Biogen Inc. announced that it will present at the Advances in Alzheimer’s and Parkinson’s Therapies, an AAT-AD/PD Focus Meeting. A...
Read more
Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body...
Read more
UrgoStart® heals 60% more patients compared to a well-managed standard treatment, and reduces healing time by 60 days (compared to...
Read more
Ocugen, Inc., a rapidly growing ophthalmology company developing a rich clinical pipeline of innovative therapies that address rare and underserved...
Read more
BioArctic AB announced that the company has received approval by the Norwegian Medicines Agency (NOMA) departments for medicinal products and...
Read more
To help ensure more affordable and timely access to patients most in need, Sanofi and Regeneron Pharmaceuticals, will offer U.S....
Read more
The European Medicines Agency (EMA) announced the recommended immediate suspension and recall of AbbVie and Biogen’s multiple sclerosis (MS) drug...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
